Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly.

[1]  A. Schuchat,et al.  Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. , 2001, JAMA.

[2]  S. Lockhart,et al.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media. , 2001, The New England journal of medicine.

[3]  L. Harrison,et al.  Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.

[4]  M. Cetron,et al.  Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. , 2000, The New England journal of medicine.

[5]  Cynthia G. Whitney,et al.  Preventing pneumococcal disease among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2000 .

[6]  R. Strikas,et al.  Influenza, pneumococcal, and tetanus toxioid vaccination of adults--United States, 1993-7. , 2000, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[7]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.

[8]  D. Fedson.  Pneumococcal conjugate vaccination for adults: why it's important for children. , 2000, The Pediatric infectious disease journal.

[9]  D. Briles,et al.  The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. , 2000, Vaccine.

[10]  K. Nichol,et al.  The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. , 1999, Archives of internal medicine.

[11]  E. Lewis,et al.  Efficacy of Heptavalent Conjugate Pneumococcal Vaccine (Wyeth Lederle) in 7,000 Infants and Children: Results of the Northern California Kaiser Permanente Efficacy Trial , 1999 .

[12]  R. Thompson,et al.  Safety of revaccination with pneumococcal polysaccharide vaccine. , 1999, JAMA.

[13]  M. Leinonen,et al.  Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people , 1998, The Lancet.

[14]  M. Leinonen,et al.  Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. , 1997, The American journal of medicine.

[15]  R. Breiman,et al.  Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .

[16]  M. Pichichero,et al.  Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults , 1997, Infection and immunity.

[17]  K. Lottenbach,et al.  Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. , 1996, The Journal of infectious diseases.

[18]  A. Lanier,et al.  Immunogenicity of pneumococcal revaccination in patients with chronic disease. , 1994, Archives of internal medicine.

[19]  R. Breiman,et al.  Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. , 1993, JAMA.

[20]  R. Adair,et al.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. , 1991, The New England journal of medicine.

[21]  M. Mufson,et al.  Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination. , 1991, Vaccine.

[22]  H. E. Krause,et al.  Pneumococcal Antibody Levels One Decade After Immunization of Healthy Adults , 1987, The American journal of the medical sciences.

[23]  A. Cross,et al.  Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. , 1986, The New England journal of medicine.

[24]  M. First,et al.  Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. , 1986, Archives of internal medicine.

[25]  M. Hilleman,et al.  Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  M. Heidelberger,et al.  Persistence of antibodies in human subjects injected with pneumococcal polysaccharides. , 1950, Journal of immunology.

[27]  M. Finland,et al.  CLINICAL SIGNIFICANCE OF BACTEREMIA IN PNEUMOCOCCIC PNEUMONIA , 1937 .